Optimal cut-off criteria for duplex ultrasound compared with computed tomography angiography for the diagnosis of restenosis in stented carotid arteries in the international carotid stenting study by Bosch, FTM et al.
 ICSS-CTA substudy 
1 
 
Optimal cut-off criteria for duplex ultrasound for the diagnosis of restenosis in stented carotid 
arteries in the International Carotid Stenting Study (ICSS): results from the CTA-substudy 
 
Cover title: diagnosis of restenosis in stented carotid artery 
 
Floris T. M. Bosch1, Jeroen Hendrikse2, Indran Davagnanam3, Leo H. Bonati4,  
Aad van der Lugt5, H. Bart van der Worp2, Gertjan de Borst2,  
Willem Mali2, Martin M. Brown,3* Paul J. Nederkoorn1* 
*Prof. Brown and Dr. Nederkoorn contributed equally to this article. 
 
1: Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands 
2: Department of Neurology and Neurosurgery, Brain Center, Rudolf Magnus, UMCU, Utrecht, the 
Netherlands 
3: UCL Institute of Neurology, the National Hospital for Neurology and Neurosurgery, London, 
United Kingdom 
4: Department of Neurology, University Hospital Basel, Basel, Switzerland 
5: Department of Radiology, Erasmus MC, University Medical Center: Rotterdam, the Netherlands 
 
Corresponding author: 
Paul J Nederkoorn, neurologist, clinical epidemiologist, Department of Neurology,  
Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, 
Telephone: +31-20-5663443, Fax: +31-20-5669374, Email: p.j.nederkoorn@amc.uva.nl 
 
 Tables: 4, Figures: 3, Word count: 2494 Abstract word count: 249 
 
 




Background and purpose: Previous studies reported that duplex-ultrasound cut-off criteria, 
based on blood velocity parameters, for the degree of stenosis in a stented carotid artery are 
higher than the established cut-offs used for unstented arteries. These studies were either 
retrospective, or the reference test was carried out only when a patient was suspected of 
having restenosis at duplex-ultrasound, which is likely to have resulted in verification bias. 
We performed a prospective study of diagnostic accuracy to find new blood velocity cut-offs 
in duplex-ultrasound for in-stent restenosis.  
Materials and methods: Stented patients within the international carotid stenting study were 
eligible. Patients had a carotid CTA in addition to routine duplex-ultrasound performed at a 
yearly follow-up. Duplex-ultrasound bloodflow velocity parameters were compared to the 
degree of stenosis on CTA. The results were analysed using ROC curves. 
Results: We included 103 patients in this study. On CTA, 30 (29.1%) patients had a 30-49% 
in-stent restenosis, 21 (20.4%) patients had 50-69% in-stent restenosis and 5 (4.9%) patients a 
≥70% in-stent restenosis. The cut-off values for ≥30% and ≥50% stenosis were a peak systolic 
velocity of 92 cm/s, (sensitivity: 74% (95% CI: 59-86), specificity: 71% (95% CI: 58-82)) and 
125 cm/s (sensitivity: 63% (95% CI: 41-79), specificity: 83% (95% CI: 72-90)).  
Conclusion: The 125 cm/s cut-off value on duplex-ultrasound is lower than found in previous 
studies and equal to unstented arteries. Duplex-ultrasound measurements made in stented 
carotid arteries should not be corrected for the presence of a stent when determining the 








DUS: duplex ultrasound 
ICSS: international carotid stenting study 
PSV: peak systolic velocity 
CAS: carotid angioplasty with stenting 
CEA: carotid endarterectomy 
CREST: carotid revascularization endarterectomy versus stent trial 
ISR: in-stent restenosis 




Carotid angioplasty with stenting (CAS) is an effective treatment for secondary prevention of 
stroke in patients with symptomatic carotid artery stenosis. Although CAS was associated 
with a higher rate of operative stroke than carotid endarterectomy (CEA) in trials such as the 
Carotid Revascularization Endarterectomy versus Stent Trial (CREST)1 and the International 
Carotid Stenting Study (ICSS)2, this risk increase appears to be limited to elderly patients3. In 
addition, CAS is still used in patients who are not suitable for CEA. Recently published data 
from ICSS shows that CAS is as effective as CEA in preventing recurrent stroke after the 
procedure4.  
An important factor in the follow-up of patients with stents is the occurrence of in-stent 
restenosis (ISR). Traditionally, the degree of stenosis in an untreated carotid artery was 
measured with conventional digital subtraction angiography (DSA). Because of a small but 
non-negligible risk of stroke or death, DSA has been replaced by non-invasive tests, such as 
duplex ultrasound (DUS), CT angiography (CTA) or MR angiography (MRA) 5,6,7. For 
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routine evaluation of unstented carotid arteries, DUS is a well-validated diagnostic test with 
established cut-off criteria for different degrees of stenosis5,6. For measurements within stents, 
however, these criteria might not suffice.  
In a stenosed artery, narrowing of the lumen results in higher blood flow velocities at that 
point. Estimating the degree of stenosis with DUS is based on this principle. The peak systolic 
velocity (PSV) threshold is one of the main criteria for grading internal carotid stenosis, 
together with diameter on B-mode image; (absence of) flow on Color Doppler image; the 
average PSV; poststenotic PSV; and collateral flow.8,9 However, it has been suggested that the 
use of PSV criteria validated in unstented arteries may overestimate the degree of (re)stenosis 
in stented arteries10.  
 
Aim 
We hypothesise that blood flow and blood turbulence behaves differently in a stent than in a 
normal vessel because the stented carotid artery has a less elastic vessel wall than a stented 
one, because the metal struts of the stent will change the elastic properties of the artery. We 
therefore hypothesised that the PSV will be higher in a stented than in an unstented carotid 
artery with a similar degree of stenosis11.  Previous studies reported higher PSV cut-offs for 
stented than for unstented arteries,12-16 but these studies were often retrospective, or the 
reference test (DSA or CTA) was carried out only when a patient was suspected of having 
restenosis at DUS, which is likely to have resulted in verification bias.17 Furthermore, 
different cut-off points have been suggested for different types of stent cell design (open 
versus closed)18.We report the results of the ICSS-CTA-DUS substudy, a prospective 
diagnostic study in which DUS parameters in patients included in ICSS who were allocated 
and treated with a carotid stent were compared to the ipsilateral degree of carotid stenosis on 
CTA.  





The ICSS is a randomised multicentre international trial in which patients aged older than 40 
years with symptomatic atherosclerotic carotid artery stenosis measuring at least 50% in 
diameter were randomly allocated treatment of the stenosis by CAS or CEA.2 Exclusion 
criteria for the trial included contraindications to stenting or surgery.  
 
Participating centres 
The participating centres were the National Hospital for Neurology and Neurosurgery, London, 
United Kingdom; Academic Medical Center, Amsterdam, the Netherlands; University Medical Centre, 
Utrecht, the Netherlands; Erasmus MC, University Medical Center: Rotterdam, the Netherlands.  
 
Patients 
The diagnostic tests were performed during routine follow-up of the ICSS trial2. In addition to 
the general ICSS criteria, patients were excluded for the substudy if they had a 
contraindication to the contrast agent used for the CTA, such as renal failure. We asked 
patients who received a stent to participate in this diagnostic study at one of the yearly follow-
up visits, at least 1 year after treatment. The substudy received approval from the Multicentre 
Research Ethics Committee in the UK and from the Ethics Committees of the participating 
centres in the Netherlands. Written informed consent was obtained from all participating 
patients.   
 
Stent type 
In ICSS stents and other devices used for carotid stenting were chosen at the discretion of the 
interventionist but had to have a CE mark. Open type stents were used as well as closed type 
stents. In this study 4 different open type stents were used, with an open space surface (OSS) > 
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5 mm3: Smart stent (Cordis, Cashel, Ireland); Precision stents (Cordis, Cashel, Ireland); 
Protegé EV3 stents (Covidien, Plymouth, USA); and Acculink stents (Guidant, Indianapolis, 
USA). 2 different closed type stents were used (OSS < 5 mm3): Carotid Wallstents (Boston 
scientific, Marlborough, USA) and next Stent (Boston scientific, Marlborough, United States).   
 
Duplex ultrasound 
DUS of the treated carotid arteries was performed by experienced vascular technician at the 
participating centres. They were blinded for CTA results. The PSV was recorded within the 
stent at the point of stenosis and in the unstented CCA. The ICA/CCA ratio was calculated 
with the analysis of the results.   
 
Reference test 
All CTAs were evaluated centrally by an experienced neuroradiologist at the UCL Institute of 
Neurology, blinded to all clinical data and the results of other diagnostic tests, at a workstation 
with reconstructions in the axial, sagittal and coronal direction. Sagittal and coronal 
reconstructions were evaluated for the presence of in-stent stenosis. Measurements to assess 
the severity of ISR were performed at the location with the most severe in-stent lumen 
reduction, either on the sagittal or coronal reconstruction. Wall-to-wall diameter 
measurements were performed by drawing a measurement line perpendicular to both vessel 
walls. A distal reference diameter was performed in the internal carotid artery distal to the 
stent where the lumen of the carotid artery has a constant diameter. These two measurements 
were used for calculating the degree of stenosis.  
 
Analyses 
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Receiver-operating-characteristic (ROC) curves were made to find the highest sensitivity and 
specificity (Q* point) for the threshold of ≥30%, ≥50% and ≥70% ISR. In these curves the 
optimal cut-off criteria for different degrees of stenosis were determined. A different analysis 
will be made in optimal cut-off values for open versus closed type stents. To assess the effects 
of verification bias a subgroup analysis was performed in patients with ≥50% stenosis based 
on established DUS criteria. Optimal cut-off criteria was defined as the highest c 
For all cut-off values sensitivity, specificity, negative predictive value (NPV), positive 
predictive value (PPV) and 95% CI were calculated. All data were analyzed using IBM SPSS 
statistics, version 21. 
 
Results 
103 patients in this study were included in ICSS between September 2003 and November 
2008. The CTA and follow-up DUS were performed between November 2004 and July 2010. 
A flow chart of the inclusion is presented in figure 1. The baseline characteristics from the 
time of randomization are presented in table 1. On CTA, 47 (45.6%) patients had ISR of 0%-
30%; 30 (29.1%) had ISR of 30%-49%; 21 (20.4%) of 50%-69%; and 5 (4.9%) of ≥70%. 
Scatter plot visualization with linear regression for the degree of stenosis on CTA and two 
different ultrasound characteristics (PSV and ICA/CCA ratio) are presented in figure 2.  
On the ROC-curves, the best cut-off values for a ≥50% stenosis on CTA were a PSV of 125 
cm/s (sensitivity: 62%, specificity: 83%) and an ICA/CCA ratio of 1.5 (sensitivity: 76%, 
specificity: 74%). (Table 2) 
Of the five patients with ISR of >70% on CTA, two had a stenosis of 71% (PSV: 183 and 185 
cm/s), one of 73% (PSV: 135 cm/s), one of 75% (PSV: 170 cm/s) and one of 76% (PSV: 220 
cm/s).  
There were no adverse events reported in this study 





Open cell versus closed cell design stents 
6 different stents were used. In 6 patients, the type of stent used was unknown. 77 open cell 
stents, with an open space surface (OSS) > 5 mm3 were used. 20 closed cell stents were used, 
with an OSS < 5 mm3. There was a significant difference in >50% ISR measured with CTA in 
open vs closed cell stents. 14 out of 77 (18%) patients with an open cell stent had a >50% ISR 
on CTA, versus 10 out of 20 (50%) in closed cell stents (p=0.003). The PSV in open cell 
stents ranged from 40 to 220 cm/s versus 78 to 220 cm/s in closed cell stents. ROC curves for 
open and close stents were separately made. The cut-off value for >50% ISR in open cell 
stents was 118 cm/s, sensitivity: 65% (95% CI: 35-87), specificity: 78% (95% CI: 66-87). The 
cut-off value for >50% ISR in closed cell stents was 128 cm/s, sensitivity: 80% (95% CI: 44-
97), specificity: 70% (95% CI: 35-93).     
 
Subgroup analysis 
In an analysis limited to the 29 ICA’s with a PSV >125 cm/s on DUS, for a >50% ISR the 
optimal cut-off PSV was 159 cm/s, sensitivity: 56% (95% CI: 25-81), specificity 56% (95% 
CI: 30-80) and an ICA/CCA ratio of 1.9, sensitivity: 63% (95% CI: 35-85), specificity: 62% 
(95% CI: 32-86)  
 
Discussion 
In this diagnostic substudy of the International Carotid Steniting Study, we found  
substantially lower cut-off values for flow velocity parameters on DUS in a stented ICA than 
previously reported, with cut-off values for a ≥50% stenosis of 125 cm/s for the PSV and 1.5 
for the ICA/CCA ratio.  
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Over the period of one to five years after CAS, we only had 5 patients (4.9%) with a severe 
stenosis (>70%). There was no correlation in ISR and amount of years after procedure. In the 
whole ICSS trial, using commonly defined ultrasound criteria (not adjusted for stents), the 
cumulative incidence of severe restenosis 5 years after completed treatment was 10.8% in the 
CAS group, and 8.6% in the CEA group, a difference which was not statistically significant4. 
Therefore we were unable to determine a threshold PSV for severe stenosis.  
As a reference test we chose CTA to compare to the velocity parameters measured with DUS. 
A diagnostic test that provides clear images of the lumen of the internal carotid artery is 
crucial, because a NASCET-like stenosis measurement is necessary as a reference to estimate 
the optimal PSV cut-offs for DUS. CTA offers high spatial resolution and contrast resolution, 
and it is a fast technique. We realise that CTA is better validated for unstented than for stented 
(carotid) arteries. The diagnostic accuracy of CTA compared to DSA, to diagnose a 70-99% 
stenosis for unstented arteries, was calculated in several studies5,7. A systematic review 
reported a sensitivity and specificity of 77% (95% CI: 68-84%) and 95% (95%CI: 91-97%) 
respectively5, but these figures are likely to underestimate the accuracy of CTA in the present 
study because the quality of CTA has improved substantially since the studies included in the 
review.  
One of the advantages of DUS for examining CAS-patients, is the ability to perform as much 
examination is wanted, since there is no risk for the patients. The comparison between DUS 
and CTA or DSA in a stented ICA has been done before and higher cut-off values were found 
in all degrees of stenosis, but previous studies often were retrospective, or the reference test 
(DSA or CTA) was carried out only when a patient was suspected of having restenosis at 
DUS, which may result in verification bias.12-16 Verification bias is introduced if the decision 
to perform the reference standard procedure depends on the results of the test under 
investigation, precluding a reliable estimate of the diagnostic accuracy of the latter.17 To our 
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knowledge this is so far the only prospective study without any possibility of verification bias 
that compares DUS to a reference test for ISR in a stented ICA. 
We identified 5 unique diagnostic series on in-stent stenosis measurements with DUS 
compared to a reference test (CTA or DSA) whom all proposed new criteria12-16. Table 3 
summarises the 5 series and this study. In general, the cut-off values are higher than those 
reported for unstented arteries. But these studies where either retrospective or included the 
patients if they had a >50 stenosis on DUS. Only Kwon et al reported a series of patients all 
undergoing both DUS and the reference test, CTA. This study, however, was too small (n=27) 
to provide new in-stent cut-off criteria19.    
To emphasise the importance of avoiding verification bias we did a sub group analysis with 
only patients with a PSV >125 cm/s, to mimic a study with DUS as a selection criterion. This 
shows a difference in optimal cut-off value of 34 cm/s only by using different selection 
criteria (table 4). This could be one explanation for the higher cut-off values for the same 
degree of stenosis observed in previous studies. 
Although differences in PSV’s in open cell stent designs versus closed cell stent designs are 
well reported, in this study the difference between these two groups remained small, with an 
optimal cut-off value for a ≥50% of 118 cm/s for open cell stents versus 128 cm/s in closed 
cell stents.  
A limitation of this study is that we had very few severe in-stent restenosis (≥70%). Theferore, 
we could not relaible estimate cut-off values for severe in-stent restenosis. In general, in the 
entire ICSS study, instent restenosis occured less frequently, later in time, and with lower 
degree of stenosis, than expected.4 
The optimum cut off value of 125 cm/s we report for stented arteries is identical to the 
"strandness" velocity criteria widely used in ultrasound laboratories to identify ≥50% stenosis 
in unstented arteries. Our data therefore suggest that DUS measurements made in stented 
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carotid arteries should not be corrected for the presence of a stent when determining the 
degree of carotid stenosis. 
 
Conclusion 
This study showed an optimal cut-off value of a PSV of 125 cm/s on DUS for the diagnosis of 
a 50% ISR and 92 cm/s for a 30% stenosis, which is lower than found in previous studies and 
equal to unstented arteries. The difference in results with the previous studies may be 
explained by avoiding verification bias. Ultrasound measurements made in stented carotid 
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Table 1. Baseline characteristics 
 No. of patients (%) 
n=103 
Age (SD) 67 (9) 
Age <70 67 (64,4) 
Male 75 (72.1) 
Median days between DUS and CTA 0 (0-29) 
Median years between CAS and CTA 2 (1-5) 
Ipsilateral carotid stenosis *  
   50-69%  94 (89,4) 
   70-99% 10 (9,7) 
Contralateral carotid stenosis  †  
   0-49% 67 (62,2) 
   50-69% 15 (14,5) 
   70-99% 15 (13,5) 
   occluded 5 (4,9) 
Prior ipsilateral stroke * 23 (22,1) 
Treated hypertension * 63 (60,6) 
Cardiac failure * 3 (2,9) 
Angina * 12 (11,5) 
Previous myocardial infarction * 12 (11,5) 
Atrial fibrillation * 5 (4,8) 
Cardio-embolic source of stroke * 4 (3,8) 
Diabetes type 2 17 (16,3) 

































   Insulin-dependent diabetes * 5 (4,8) 
   Non-insulin-dependent diabetes * 12 (11,5) 
Current smoker * 35 (33,7) 
Ex-smoker * 42 (40,4) 
Previous CABG * 13 (12,5) 
Peripheral arterial disease * 12 (11,5) 
*  data of 1 patient missing 
†  data of 2 patients missing  




Table 2. cut-off values for blood velocity parameters on DUS for ≥30% and ≥50% stenosis in 












≥30%        
   PSV 92 cm/s 74 59-86 71 58-82 76 69 
   ICA/CCA 1.2 69 54-80 67 51-79 70 65 
≥50%        
   PSV 125 cm/s 62 41-79 83 72-90 55 86 
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PSV   
≥50% 
PSV      
≥70% 
PSV                   
≥80% 
Stanziale17 2005 605 No Yes 118 DSA  225 350  
Chi16 2007 260 Yes Yes 13 DSA  240 450  
Aburhama1
3 
2008 144 Yes Yes 144 CTA 178 278  403 
Lal14 2008 225 No Yes 99 CTA/DSA  220  340 
Zhou15 2008 256 No Yes 22 DSA   300  
Bosch 2015 103 Yes No - CTA 92 125   
* Selection of a subgroup based on DUS results (the test under evaluation) indicates possible verification bias. These subgroups are 
compared to the reference test in order to obtain the listed DUS cut-off values.  
** Suggested cut-offs for in-stent restenosis measurements based on the peak systolic velocity (PSV); in cm/sec 
 
 




Table 4. Optimal cut-off criteria with and without verification bias 




Sensitivity specificity PSV Cm/s sensitivity specificity 
38 100 0 128 100 0 
49 100 8 129 94 0 
56 94 12 131 94 23 
77 85 31 133 88 23 
81 85 47 138 69 23 
97 77 62 146 63 23 
109 65 75 154 56 46 
125 * 62 83 159 * 46 63 
131 58 87 168 39 63 
145, 39 87 177 39 75 
158 35 92 181 39 61 
177 15 ,94 184 13 61 
187 4 94 192 4 69 
197 4 96 197 4 84 
221 0 100 221 0 100 
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Left: optimal cut-off criteria for a ≥50% stenosis in this study. Right: hypothetical 
optimal cut-off criteria if only patients with a PSV >125cm/s on DUS would have 
been included in this study 
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